VIVUS to Present at Three Investor Conferences in March 2013

VIVUS to Present at Three Investor Conferences in March 2013

MOUNTAIN VIEW, Calif., March 4, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc.
(Nasdaq:VVUS) today announced that management will present an overview of the
company at three investment conferences during the month of March 2013.

The conference presentation schedule is as follows:

Cowen and Company 33rd Annual Health Care Conference
March 5, 2013, 8:00am EST
Boston Marriott Copley Place
Boston, MA

Barclays Global Healthcare Conference
March 14, 2013, 9:00am EST
Loews Miami Beach Hotel
Miami Beach, FL

Roth 25th Annual Conference
March 19, 2013, 1:00pm PST
The Ritz Carlton Laguna Niguel
Dana Point, CA

A live webcast and 30-day archive of the presentations will be available at


VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in obesity, sleep
apnea, diabetes and sexual health for U.S., Europe and other world markets.
For more information about the company, please visit

Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS' Form
10-K for the year ending December 31, 2012, and periodic reports filed with
the Securities and Exchange Commission.

         Timothy E. Morris
         Chief Financial Officer
         Financial Media Relations:
         Joele Frank, Wilkinson Brimmer Katcher
         Jennifer Beugelmans
         (212) 895-8692
         Investor Relations:
         The Trout Group
         Brian Korb
Press spacebar to pause and continue. Press esc to stop.